Anti-Glaucoma Eye Drops Franchise in Ahmedabad

Bimatoprost + Timolol Eye Drops Supplier in Mumbai

Ophthalmic Glaucoma Care Distributor in Delhi

Eye Pressure Control Pharma Franchise in Bangalore

Bimatoprost Timolol Eye Drops Stockist in Hyderabad
Anti-Glaucoma Combination Ophthalmic Drop Manufacturer & Exporter in Chandigarh

Home/Products /bimatoprost-0-3mg-ml-timolol-5mg-ml-eye-drop

Optiprost T Eye Drop

Composition : Bimatoprost (0.3mg/ml) + Timolol (5mg/ml) Eye Drops

Dosage Form : Eye Drops

Packaging Type : Dropper

Packaging : 10ml

Price : ₹0/-

Optiprost T Eye Drop contains Bimatoprost 0.3mg/ml + Timolol 5mg/ml, a dual-action anti-glaucoma ophthalmic formulation used for effective reduction of elevated intraocular pressure in patients with glaucoma and ocular hypertension. Its precise combination ensures enhanced pressure control with long-term safety.

The eye drop works by increasing aqueous humor outflow through Bimatoprost and reducing aqueous humor production via Timolol, delivering comprehensive intraocular pressure management and protecting optic nerve health.

From a franchise perspective, Optiprost T Eye Drop is a high-demand combination therapy, commonly prescribed in eye hospitals, specialty ophthalmology clinics, and glaucoma care centers, ensuring consistent prescriptions and repeat sales.

Adding Optiprost T Eye Drop to your portfolio strengthens the ophthalmic anti-glaucoma combination segment, offering long-term market stability, strong prescriber confidence, and enhanced portfolio value for PCD pharma franchise partners.


Read More

About the Product

Optiprost T Eye Drop contains Bimatoprost 0.3mg/ml + Timolol 5mg/ml, a dual-action anti-glaucoma ophthalmic formulation used for effective reduction of elevated intraocular pressure in patients with glaucoma and ocular hypertension. Its precise combination ensures enhanced pressure control with long-term safety.

The eye drop works by increasing aqueous humor outflow through Bimatoprost and reducing aqueous humor production via Timolol, delivering comprehensive intraocular pressure management and protecting optic nerve health.

From a franchise perspective, Optiprost T Eye Drop is a high-demand combination therapy, commonly prescribed in eye hospitals, specialty ophthalmology clinics, and glaucoma care centers, ensuring consistent prescriptions and repeat sales.

Adding Optiprost T Eye Drop to your portfolio strengthens the ophthalmic anti-glaucoma combination segment, offering long-term market stability, strong prescriber confidence, and enhanced portfolio value for PCD pharma franchise partners.


Common side effects may include eye redness, burning or stinging sensation, itching, blurred vision, or foreign body sensation. Rarely, systemic effects such as slow heart rate, fatigue, dizziness, or breathing difficulty may occur due to Timolol. Changes in eyelash growth or iris pigmentation may occur with prolonged use.

Optiprost T Eye Drop is indicated for the management of open-angle glaucoma and ocular hypertension in patients who do not achieve adequate pressure control with single-agent therapy. It helps reduce elevated intraocular pressure and protects against optic nerve damage under ophthalmologist supervision.

Use Optiprost T Eye Drop strictly as prescribed by an ophthalmologist. Avoid touching the dropper tip to the eye to prevent contamination. Use with caution in patients with asthma, chronic obstructive pulmonary disease, or cardiac conditions. Inform your doctor immediately if breathing difficulty, vision changes, or severe eye irritation occurs.

Store in a cool, dry place below 25 °C. Protect from direct sunlight, keep the bottle tightly closed, and out of reach of children. Do not use after the expiry date.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation